FDA-Approved ADCs: Breaking New Ground in Breast, Lung, and Gastric Cancer Treatment Check out our extensive video library (see channel for our latest videos) Introduction FDA-approved ADCs are revolutionizing cancer treatment landscapes, as the fifth most prevalent malignancy globally, gastric cancer ranks
Author: Similoluwa Oluwalana
Critical Updates in TP53 MDS Prognosis: 2025 Findings
AI-Powered Clinical Decision Support in Neurology: Help or Hindrance?
AI-Powered Clinical Decision Support in Neurology: Help or Hindrance? Check out our extensive video library (see channel for our latest videos) Abstract This paper examines the application of artificial intelligence (AI) in neurology to assist doctors in making informed decisions about patient care. We
Hemophilia Prophylaxis in the Era of Non-Factor Therapies
Hemophilia Prophylaxis in the Era of Non-Factor Therapies Check out our extensive video library (see channel for our latest videos) Abstract Hemophilia treatment has changed dramatically with the introduction of non-factor therapies. This paper examines how these new treatments affect prophylactic care for
Hidden Cognitive Decline Symptoms: What Every Internist Must Know Today
Hidden Cognitive Decline Symptoms: What Every Internist Must Know Today Check out our extensive video library (see channel for our latest videos) Introduction Cognitive decline symptoms often go undetected in clinical settings, despite affecting approximately 16.6% of Americans aged 65 and older who experience
Alternative Therapies for Depression: Breakthrough Neurostimulation Methods Show 80% Success Rate
Alternative Therapies for Depression: Breakthrough Neurostimulation Methods Show 80 Percent Success Rate Check out our extensive video library (see channel for our latest videos) Introduction Alternative therapies for depression have gained crucial importance as traditional antidepressant medications relieve symptoms in only about one-third of
Why GLP-1 Non-Responders Need Earlier Anti-Obesity Medication Intervention
Why GLP-1 Non-Responders Need Earlier Anti-Obesity Medication Intervention Introduction GLP-1 non-responders represent a critical challenge in obesity management that requires prompt medical intervention. Despite the availability of six FDA-approved anti-obesity medications (AOMs) for chronic weight management, current guidelines recommend waiting six months after behavioral therapy
Tachyphylaxis in Antidepressants: The Science Behind Treatment Resistance
Tachyphylaxis in Antidepressants: The Science Behind Treatment Resistance Introduction Tachyphylaxis is a challenging phenomenon that occurs when antidepressant medications gradually lose their therapeutic efficacy despite continued administration at the same dosage. The prevalence of antidepressant treatment tachyphylaxis is substantial, affecting approximately 25 percent of treated,
The Opioid Crisis in Family Practice: Safe Prescribing vs. Abandoning Patients
The Opioid Crisis in Family Practice: Safe Prescribing vs. Abandoning Patients Abstract The opioid crisis has placed family practice doctors in a challenging position. They must balance providing proper pain care for their patients while avoiding contributing to the widespread addiction and overdose problems facing
CBD and Seizures: New Clinical Evidence Challenges Common Beliefs
CBD and Seizures: New Clinical Evidence Challenges Common Beliefs Introduction CBD and seizures research has skyrocketed in recent years, challenging traditional treatment paradigms for refractory epilepsy. Epilepsy affects approximately 50 million people globally, according to the World Health Organization (WHO). This neurological disorder, previously limited
